Your browser doesn't support javascript.
loading
Treatment of Kleine-Levin Syndrome With Intranasal Photobiomodulation and Methylene Blue.
Hamper, Michael; Cassano, Paolo; Lombard, Jay.
Afiliação
  • Hamper M; Neurology, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, USA.
  • Cassano P; Psychiatry, Massachusetts General Hospital, Boston, USA.
  • Lombard J; Neurosciences, Root Cause Medicine Practice, Tarrytown, USA.
Cureus ; 13(10): e18596, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34659921
ABSTRACT
Kleine-Levin syndrome (KLS) is a rare neuropsychiatric disorder, characterized by recurrent episodes of idiopathic hypersomnia, and cognitive and behavioral abnormalities, such as memory loss and child-like language. There is no definitive etiology for KLS; however, there are hypotheses of genetic predisposition, autoimmune mechanisms, and abnormal thalamic and hypothalamic functioning. Similarly, there is no definitive treatment for KLS as one method may be beneficial for one patient and not for another. We present a case of KLS in a patient who has no clinical improvement in symptoms with a variety of treatments. The parents of the patient agreed to attempt a trial of intranasal photobiomodulation (i-PBM) with red light, in combination with methylene blue (MB). The patient showed remission of the KLS episode following treatment with no further KLS episodes reported after treatment.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article